Other partners

The Council collaborates with WHO/Europe through its European Directorate for the Quality of Medicines (EDQM), especially through its European Committee on Pharmaceuticals and Pharmaceutical Care, on the issues of counterfeit medicines, and quality and safety standards for pharmaceutical practices and pharmaceutical care.

ECDC is a key partner in antimicrobial resistance-related activities.

WHO/Europe collaborates with the European Union through direct policy consultation and networking initiatives, including the Pharmaceutical Pricing and Reimbursement Information Network, the Pharmaceutical Health Information System Network and the Network of Competent Authorities on Pricing and Reimbursement. WHO/Europe also maintains regular contact and consultation with the European Medicines Agency on medicines regulation.

This international financing institution supports large-scale projects. WHO/Europe assists countries in complying with Global Fund quality requirements for pharmaceutical products.

HAI collaborates closely with WHO in the monitoring of prices in Member States and in the responsible use of medicines with a special focus on regulation of promotion.

This initiative of the United Kingdom Department for International Development brings together international institutions, governments, civil society and business to improve the health of some of the world’s most disadvantaged people. The second phase of this alliance is guided by WHO and Health Action International.

This partner collaborates with WHO on high-price medicines.

This multidisciplinary network of professionals share the common vision of enhancing the health of the public and the individual patient in a sustainable way through exchanging ideas and co-operation around the responsible use of pharmacological and related therapies.

WHO/Europe works with World Bank country offices in Member States on projects focusing on national policies, quality assurance and responsible use of medicines.